Drug repurposing screen identifies novel classes of drugs with anticancer activity in mantle cell lymphoma.

CONCLUSION: This is the first study to examine such a large library of clinically approved compounds for the identification of novel drug candidates for MCL treatment, the results could be rapidly translated into clinical practice in patients with MCL.
PMID: 31526347 [PubMed - as supplied by publisher]

Source: Combinatorial Chemistry and High Throughput Screening - September 15, 2019 Category: Chemistry Authors: Han C, Yu X, Zhang C, Cao Y, Cai Y, Wang S, Shen J Tags: Comb Chem High Throughput Screen Source Type: research